Logo image
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci
Journal article   Open access   Peer reviewed

Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci

Daniel J Diekema, Janet I Andrews, Holly Huynh, Paul R Rhomberg, Stella R Doktor, Jill Beyer, Virginia D Shortridge, Robert K Flamm, Ronald N Jones and Michael A Pfaller
Journal of clinical microbiology, Vol.41(6), pp.2659-2661
06/2003
DOI: 10.1128/JCM.41.6.2659-2661.2003
PMCID: PMC156484
PMID: 12791897
url
https://doi.org/10.1128/JCM.41.6.2659-2661.2003View
Published (Version of record) Open Access

Abstract

Pulsed-field gel electrophoresis (PFGE) was performed on 122 neonatal bloodstream isolates of group B streptococci (GBS) to further examine the relationship between macrolide resistance and serotype V GBS (GBS-V). Over one-third (35%) of macrolide-resistant GBS belonged to a single PFGE subtype of GBS-V, which was also the most common GBS-V subtype noted in previous Centers for Disease Control and Prevention surveillance studies. Erm methylase (ermA and ermB) was the most common resistance mechanism detected, present in 12 of 20 macrolide-resistant GBS.
Streptococcal Infections - microbiology Streptococcus agalactiae - drug effects Macrolides Humans Bacterial Proteins - genetics Methyltransferases - genetics Streptococcus agalactiae - classification Blood - microbiology Electrophoresis, Gel, Pulsed-Field Bacteremia - microbiology Microbial Sensitivity Tests Streptococcus agalactiae - genetics Streptococcus agalactiae - isolation & purification Molecular Epidemiology Anti-Bacterial Agents - pharmacology Drug Resistance, Bacterial - genetics Infant, Newborn Serotyping

Details

Metrics

Logo image